Caplin Point Laboratories Q4 Results
- BSE: 524742
- NSE: CAPLIPOINT
- ISIN: INE475E01026
- Sector: Biotechnology & Drugs
BSE
2,280.00
29.05 (1.29%)
29.05 (1.29%)Volume5.58 K
Updated: Thu 22 May, 2025 | 15:29:01
NSE
2,288.5036.10 (1.60%)
36.10 (1.60%)Volume1.80 L
Updated: Thu 22 May, 2025 | 15:31:16
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
- Total Income₹502.45 Cr.(10.86%)
- Operating Profit₹151.02 Cr.(17.22%)
- Profit After Tax₹142.57 Cr.(17.25%)
- Operating Margin30.06%(5.74%)
Note: Comparison is on YoY basis
Quarterly - Caplin Point Laboratories Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 25 | Dec 24 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 502.45 | 492.96 | 1.93% | 453.22 | 10.86% |
| Selling/ General/ Admin Expenses Total | 46.51 | 46.77 | -0.56% | 36.77 | 26.49% |
| Depreciation/ Amortization | 17.04 | 16.20 | 5.19% | 16.40 | 3.90% |
| Other Operating Expenses Total | 86.68 | 88.55 | -2.11% | 6.13 | 1314.03% |
| Total Operating Expense | 351.43 | 346.87 | 1.31% | 324.39 | 8.34% |
| Operating Income | 151.02 | 146.09 | 3.37% | 128.83 | 17.22% |
| Net Income Before Taxes | 176.67 | 177.26 | -0.33% | 146.03 | 20.98% |
| Net Income | 142.57 | 138.96 | 2.60% | 121.59 | 17.25% |
| Diluted Normalized EPS | 18.69 | 18.19 | 2.75% | 15.90 | 17.57% |